Table of Contents
-
Quantitative Analysis of Multi-Species Oral Biofilms by TaqMan Real-Time PCR
Nao Suzuki, Akihiro Yoshida and Yoshio Nakano- Clinical Medicine & Research August 2005, 3 (3) 176;
- DOI: https://doi.org/10.3121/cmr.3.3.176
-
Radioimmunotherapy for Non-Hodgkin’s Lymphoma
Arati V. Rao, Gamal Akabani and David A. Rizzieri- Clinical Medicine & Research August 2005, 3 (3) 157;
- DOI: https://doi.org/10.3121/cmr.3.3.157
-
Bringing Mysteries Into Daylight
Bruce C. Rhoades- Clinical Medicine & Research August 2005, 3 (3) 133;
- DOI: https://doi.org/10.3121/cmr.3.3.133
-
Diagnosis — Disseminated Toxoplasmosis
Christopher J. Cold, Thomas L. Sell and Kurt D. Reed- Clinical Medicine & Research August 2005, 3 (3) 186;
- DOI: https://doi.org/10.3121/cmr.3.3.186
-
Serologic Testing in Connective Tissue Diseases
Dana E. Habash-Bseiso, Steven H. Yale, Ingrid Glurich and Jerry W. Goldberg- Clinical Medicine & Research August 2005, 3 (3) 190;
- DOI: https://doi.org/10.3121/cmr.3.3.190
-
Radioimmunotherapy for Non-Hodgkin’s Lymphoma
Arati V. Rao, Gamal Akabani and David A. Rizzieri- Clinical Medicine & Research August 2005, 3 (3) 157;
- DOI: https://doi.org/10.3121/cmr.3.3.157
-
Radioimmunotherapy for Non-Hodgkin’s Lymphoma
Arati V. Rao, Gamal Akabani and David A. Rizzieri- Clinical Medicine & Research August 2005, 3 (3) 157;
- DOI: https://doi.org/10.3121/cmr.3.3.157
-
A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data
Michael A. Hillman, Russell A. Wilke, Steven H. Yale, Humberto J. Vidaillet, Michael D. Caldwell, Ingrid Glurich, Richard L. Berg, John Schmelzer and James K. Burmester- Clinical Medicine & Research August 2005, 3 (3) 137;
- DOI: https://doi.org/10.3121/cmr.3.3.137
-
Serologic Testing in Connective Tissue Diseases
Dana E. Habash-Bseiso, Steven H. Yale, Ingrid Glurich and Jerry W. Goldberg- Clinical Medicine & Research August 2005, 3 (3) 190;
- DOI: https://doi.org/10.3121/cmr.3.3.190
-
A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data
Michael A. Hillman, Russell A. Wilke, Steven H. Yale, Humberto J. Vidaillet, Michael D. Caldwell, Ingrid Glurich, Richard L. Berg, John Schmelzer and James K. Burmester- Clinical Medicine & Research August 2005, 3 (3) 137;
- DOI: https://doi.org/10.3121/cmr.3.3.137
Akihiro Yoshida
Arati V. Rao
Bruce C. Rhoades
Christopher J. Cold
Dana E. Habash-Bseiso
David A. Rizzieri
Gamal Akabani
Humberto J. Vidaillet
Ingrid Glurich
In this Issue
Issue Highlights
- Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
- Birds, Migration and Emerging Zoonoses: West Nile Virus, Lyme Disease, Influenza A and Enteropathogens
- Patient Characteristics Associated with Medication Adherence
- Healthcare Workers Emotions, Perceived Stressors and Coping Strategies During a MERS-CoV Outbreak
- Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer


